Tag: R&D
ContextVision’s Digital Pathology Continues To Move Forward Based On Rigorous R&D
ContextVision, a medical technology software company
specializing in image analysis and artificial intelligence, continued to
advance its artificial intelligence portfolio in the second quarter 2019. The
company’s AI-based product Altumira™ for X-ray is now commercially available
and INIFY Prostate for digital pathology will...
Nottingham Health Science Biobank
The Nottingham Health Science Biobank, located in Nottingham, England, provides researchers with samples for a wide range of cancers and other disease conditions. The Nottingham Health Science Biobank is a trust-led biobank funded by a development grant from the...
Biobanking Science: Pharmacogenetics Study from the Estonian Biobank
People with the same diagnosis may react very differently to a prescription medication. The same drug may cure one set of patients, cause toxic side effects in another group and have limited effects in a third group. For many...
Biobanking Science: Biomarkers for Traumatic Brain Injury
Traumatic brain injury has been in the news lately because even mild traumatic brain injury, or concussion, can increase the risk of developing neurodegenerative diseases like Parkinson’s disease (1). Many parents have understandably been worried about their children suffering...
Biobanking Science: Biobanks Tackle Chronic Kidney Disease
Chronic kidney disease is common. The prevalence of chronic kidney disease has rapidly increased over the past 20 years, and it now affects 13% of people around the world (1). Chronic kidney disease can be difficult to treat because...
3D Liver Structures Developed By International Stem Cell Corporation
International Stem Cell Corporation (ISCO), founded in 2001, and headquartered in Carlsbad, California, is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products.
The liver works to...
Emulate Inc.’s Organs-On-Chips Technology Secures $36 Million Financing
Emulate Inc., has secured a $36 million Series C financing round led by Founders Fund. With the financing transaction, Aaron VanDevender, Chief Scientist and Principal at Founders Fund, joins Emulate’s board of directors.
Founders Fund is a leading Bay Area...
Biobanking Science: Measuring Cell-Free Tumor DNA
Circulating cell-free tumor DNA (cfDNA) is released by solid tumors into the blood stream. There is a lot of interest among the medical and biobanking communities in using cfDNA as a relatively non-invasive way of predicting cancer prognosis and...
New Insight Into The FTO Gene And Obesity Risk Made Possible By FitnessGenes Customers
FitnessGenes Ltd. is a DNA-testing company offering fitness and nutrition guidance. With an in-mail spit collection DNA kit and in-house analysis of 41 gene variations, that reveal specific personal traits including metabolic tendencies, dietary sensitivities, fat burning capacity, muscle...
